Showing results (371-380 of 381) with videos related to
Sort By:
Pageof 39
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 9, 2025
Discovery of a Thrombin-Targeting Anticoagulant Peptide From Whitmania pigra via a "Computation-Guided Experimentation" StrategyYu-Tong Hua, Rui-Juan Dong, Yin Li, et al.Shock (Augusta, Ga.)|February 16, 2026
TIPE2-Regulated ER-phagy in Dendritic Cell Function Following Hemorrhagic ShockShi-Ying Yang, Miao Jiang, Hu Jiang, et al.Communications Biology|July 11, 2020
Mandarin fish (Sinipercidae) genomes provide insights into innate predatory feedingShan He, Ling Li, Li-Yuan Lv, et al.The Oncologist|October 30, 2016
Chemotherapy Near the End of Life for Chinese Patients with Solid MalignanciesJin Sheng, Ya-Xiong Zhang, Xiao-Bo He, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
Analysis of the curative effect and influencing factors of stereotactic aspiration in the treatment of primary brainstem haemorrhageYan Li, Dong-Xue Wu, Jian-Feng Liu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 29, 2024
EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47Li-Yang Hu, Wei-Tao Zhuang, Mao-Jian Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependentAdrienne L King, David J Polhemus, Shashi Bhushan, et al.Scientific Reports|March 31, 2016
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplexZhi-Yao He, Feng Deng, Xia-Wei Wei, et al.The Journal of Clinical Investigation|January 15, 2026
EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γWei-Tao Zhuang, Lan-Lan Pang, Li-Yang Hu, et al.Journal of Hematology & Oncology|February 7, 2025
Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trialGang Chen, Dong-Chen Sun, Yi Ba, et al.Pageof 39